Literature DB >> 6445764

Treatment of aplastic anemia by bone marrow transplantation in identical twins.

F R Appelbaum, A Fefer, M A Cheever, J E Sanders, J W Singer, J W Adamson, E M Mickelson, J A Hansen, P D Greenberg, E D Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6445764

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

Review 1.  Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-Ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell Rosse; Gerard Socié
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

2.  Survival and quality of life in 23 patients with severe aplastic anemia treated with bone marrow transplantation (BMT).

Authors:  W Hinterberger; H Gadner; P Höcker; A Hajek-Rosenmayr; W Graninger; G Grabner; B Volc-Platzer; R Hawliczek; K H Kärcher; W Kallinger
Journal:  Blut       Date:  1987-03

Review 3.  Progress in bone marrow transplantation in man.

Authors:  R P Gale
Journal:  Surv Immunol Res       Date:  1982

Review 4.  Preparation for bone marrow transplantation.

Authors:  R Parkman
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.

Authors:  N C Zoumbos; P Gascon; J Y Djeu; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation.

Authors:  Sabine Gerull; Martin Stern; Jane Apperley; Dietrich Beelen; Lorentz Brinch; Donald Bunjes; Andrew Butler; Arnold Ganser; Ardeshir Ghavamzadeh; Mickey B Koh; Mieczyslaw Komarnicki; Nicolaus Kröger; Johan Maertens; Alexei Maschan; Christina Peters; Montserrat Rovira; Henrik Sengeløv; Gerard Socié; Johanna Tischer; Rosi Oneto; Jakob Passweg; Judith Marsh
Journal:  Haematologica       Date:  2013-07-26       Impact factor: 9.941

7.  Immune suppression therapy in aplastic anemia: influencing factors on response and survival.

Authors:  J Y Jin; D W Kim; J W Lee; C W Han; W S Min; C W Park; C C Kim; D J Kim; H K Kim; H H Song
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

8.  Immunomodulation therapy for severe aplastic anemia--ALG versus ALG plus cyclosporin A.

Authors:  C W Park; C H Han; C C Kim; D J Kim; H K Kim
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.